Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BSX vs GSK✓SelectedUSD · GSKBSX vs GSK performance historyLatest closeAs of-1.47%11/16
Stock and ETF performance explorer

BSX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+104.5%
GSK return
+107.3%
Excess return
-2.7%
Maximum drawdown
-61.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-0.1%-1.4%-1.4%
7D-0.7%-1.3%+0.6%-0.3%
30D-1.6%+2.7%-4.3%-2.5%
3M-15.7%+2.7%-18.4%-16.5%
6M-17.1%+3.3%-20.4%-18.1%
YTD-54.2%+6.5%-60.6%-55.8%
1Y-57.5%+10.7%-68.1%-59.7%
3Y-20.1%+64.4%-84.4%-38.9%
5Y+5.5%+46.7%-41.2%-16.2%
10Y+104.5%+109.4%-4.8%+31.4%
All+104.5%+107.3%-2.7%+31.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling